Our Scientific Advisory Board

Like everything we do, our scientific advisory board far exceeds the traditional "medical advisory board" of our peers. We searched the world to gather those involved with groundbreaking research and clinical applications to help direct our research to discover the next big thing in nutritional science.

We selected these board members to represent the disciplines that are the focus of our product development and clinical research areas—such as insulin signaling, inflammation, cell repair, and muscle physiology. They bring years of experience and broad-based expertise from institutional and academic appointments to pharmaceutical engagements in developing cholesterol management and cardiovascular protection technologies.

This guidance helps us to secure patents and published research for breakthrough and unique nutrient applications. But more importantly, it helps us deliver more effective natural options for helping to reverse chronic illness and improve health.


Vincenzo Castronovo, MD, PhD
Vincenzo Castronovo, MD, PhD
Director of the Metastasis Research Laboratory, Center for Experimental Cancer Research, University of Liège



Edward A. Dennis, PhD Edward A. Dennis, PhD
Professor, Dept of Chemistry and Biochemistry, University of California at San Diego School of Medicine and Revelle College



Joel M. Evans, MD Joel M. Evans, MD
Obstetrician/Gynecologist
Director of the Center for Women’s Health



Barry M. Forman MD, PhD Barry M. Forman MD, PhD
Director of the Department of Gene Regulation and Drug Discovery
Professor of the Division of Molecular Medicine and Department of Diabetes, Endocrinology & Metabolism at the Beckman Research Institute of City of Hope National Medical Center


Louis J. Ignarro, PhD
Louis J. Ignarro, PhD
Distinguished Professor, Department of Molecular and Medical Pharmacology, University of California, Los Angeles



David J.A. Jenkins, MD, PhD, DSc David J.A. Jenkins, MD, PhD, DSc
Professor and Canada Research Chair of Nutrition and Metabolism in the Dept of Nutritional Sciences at the Univ of Toronto
Director of the Clinical Nutrition and Risk Factor Modification Center at St. Michaels’ Hospital



John F.W. Keana, PhD
John F.W. Keana, PhD
Professor Emeritus of Synthetic Organic and Medicinal Chemistry at the University of Oregon



Roger S. Newton, PhD Roger S. Newton, PhD
Senior Vice President of Pfizer Global Research & Development
Director of Esperion Therapeutics



Philipp E, Scherer, PhD
Philipp E, Scherer, PhD
Professor of Internal Medicine, Director, Touchstone Center for Diabetes Research at University of Texas Southwestern Medical Center at Dallas


Jeffrey S. Bland, PhD, FACN, CNS Jeffrey S. Bland, PhD, FACN, CNS
Chief Science Officer of Metagenics, Inc.
President of the MetaProteomics Nutrigenomics Research Center



Robert H. Lerman, MD, PhD
Robert H. Lerman, MD, PhD
Director of Medicine and Extramural Clinical Research for Metagenics, Inc.



Matthew L. Tripp, PhD
Matthew L. Tripp, PhD
Vice President of Research and Development for Metagenics, Inc. and the MetaProteomics Nutrigenomics Research Center